The post Holly Buckley appeared first on The BTI Consulting Group.

Her practice includes advising healthcare providers, sponsors, and lenders to the healthcare industry. In representing healthcare providers, Diana works with hospitals, ambulatory surgery centers, dental services organizations (DSOs), and large physician group practices.

The post Diana C. Castro appeared first on The BTI Consulting Group.

The post Amanda K. Roenius appeared first on The BTI Consulting Group.

Brad’s practice also involves all aspects of medical malpractice litigation, including medical review panel proceedings, litigation, appeals and administrative adjudication proceedings brought before the Louisiana State Board of Medical Examiners, Louisiana State Board of Nursing, the Louisiana State Board of Dentistry and the Louisiana Physical Therapy Board. He represents healthcare facilities, including a Political Subdivision-Hospital Service District, employed and independent contractor physicians, nurses, pharmacists, dentists, physical therapists in cases arising in all areas of the treatment setting including, surgery, obstetrics and gynecology, invasive gastroenterology, hospital medicine, patient transport, patient supervision, emergency medicine, bloodborne pathogens, EMTALA, medical products liability and acute setting nursing care.

The post Bradley R. Belsome appeared first on The BTI Consulting Group.

His regulatory practice focuses on billing and coding, overpayment disputes, government audits, HIPAA compliance, False Claims Act issues, Stark/Anti-Kickback compliance, and day-to-day operational issues. Working extensively with state agencies, CMS, state Medicaid agencies, and accreditation bodies, Colin helps clients maintain compliance with licensure, enrollment, and certification requirements while minimizing operational disruptions.

The post Colin P. McCarthy appeared first on The BTI Consulting Group.

Mr. Wasserstein is the co-founding blogger of the FDA Law Blog, the industry’s foremost resource for insight on food and drug regulation and enforcement actions. He is widely regarded as an industry thought leader in the use of social media to market regulated products that fall under the purview of FDA and the FTC: pharmaceuticals, biotech, medical devices, as well as foods and supplements. Mr. Wasserstein authored a chapter on social media, “Using Social Media in FDA-Regulated Industries: The Essential Guide,” FDLI, 2010. He also advises an online publisher on social media best practices with regard to regulated industries.

The post Jeffrey N. Wasserstein appeared first on The BTI Consulting Group.

Danny regularly tries cases and arbitrations in Tennessee, Arkansas and Mississippi. He has tried an arbitration or case in 16 states and three foreign countries. He is known as a practical problem solver who has a keen sense of a client’s ultimate business objective and keeps that in focus throughout the life of the case.

The post Daniel W. Van Horn appeared first on The BTI Consulting Group.

Brian is a member of ArentFox Schiff’s Executive Committee and has previously served as co-manager of the firm’s Regulatory Department and practice leader for the Food, Drug, Medical Device & Cosmetic group.

The post Brian P. Waldman appeared first on The BTI Consulting Group.

The post David A. King appeared first on The BTI Consulting Group.

The post Garrett T. Jackson appeared first on The BTI Consulting Group.